Media headlines about Acadia Healthcare (NASDAQ:ACHC) have trended somewhat positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Acadia Healthcare earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.6970125586362 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
- Acadia Healthcare Company, Inc. (ACHC) President Brent Turner Sells 206,252 Shares (americanbankingnews.com)
- Acadia Healthcare Company, Inc. (ACHC) COO Ronald Morgan Fincher Sells 80,000 Shares (americanbankingnews.com)
- Insider Selling: Acadia Healthcare Company, Inc. (ACHC) EVP Sells 53,713 Shares of Stock (americanbankingnews.com)
- Joey A. Jacobs Sells 500,000 Shares of Acadia Healthcare Company, Inc. (ACHC) Stock (americanbankingnews.com)
- Acadia Healthcare Company, Inc. (ACHC) Director Sells $49,882,761.75 in Stock (americanbankingnews.com)
Acadia Healthcare (NASDAQ ACHC) opened at 47.62 on Wednesday. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.34. The firm’s 50-day moving average is $50.46 and its 200-day moving average is $45.23. The stock has a market cap of $4.18 billion, a P/E ratio of 523.30 and a beta of 1.15.
Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. The company had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The firm’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same period last year, the business posted $0.73 earnings per share. On average, equities analysts forecast that Acadia Healthcare will post $2.45 earnings per share for the current fiscal year.
Several brokerages have recently weighed in on ACHC. Mizuho boosted their price objective on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. BidaskClub upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, June 10th. Craig Hallum reiterated a “buy” rating and issued a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Leerink Swann downgraded shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research report on Monday, May 15th. Finally, UBS AG reiterated a “positive” rating and issued a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. One analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Acadia Healthcare has an average rating of “Buy” and an average price target of $59.21.
WARNING: “Acadia Healthcare (ACHC) Getting Somewhat Favorable News Coverage, Study Shows” was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/23/acadia-healthcare-achc-getting-somewhat-favorable-news-coverage-study-shows.html.
In other Acadia Healthcare news, President Brent Turner sold 206,252 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $10,454,913.88. Following the sale, the president now directly owns 81,106 shares in the company, valued at $4,111,263.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Christopher L. Howard sold 53,713 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the sale, the executive vice president now owns 147,286 shares in the company, valued at $7,465,927.34. The disclosure for this sale can be found here. Insiders sold 3,962,387 shares of company stock worth $197,947,257 over the last quarter. 11.10% of the stock is currently owned by company insiders.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
